Trade Zynex, Inc. - ZYXI CFD

Zynex, Inc. Company profile

About Zynex Inc.

Zynex, Inc. designs, manufactures and markets medical devices, which treats chronic and acute pain, as well as activate and exercise muscles for rehabilitative purposes with electrical stimulation. The Company’s devices are intended for pain management to reduce reliance on drugs and medications and provide rehabilitation and increased mobility through the utilization of non-invasive muscle stimulation, electromyography technology, interferential current (IFC), neuromuscular electrical stimulation (NMES) and transcutaneous electrical nerve stimulation. The Company’s medical devices are small, portable, battery operated and include an electrical pulse generator, which is connected to the body via electrodes. Its primary product is the NexWave device. The NexWave is marketed to physicians and therapists by its field sales representatives. The NexWave requires consumable supplies, such as electrodes and batteries, which are shipped to patients on a recurring monthly basis, as needed.

Financial summary

BRIEF: For the fiscal year ended 31 December 2021, Zynex Inc. revenues increased 63% to $130.3M. Net income increased 88% to $17.1M. Revenues reflect Supplies increase of 59% to $93.7M, Devices increase of 72% to $36.6M. Net income benefited from Rental Expense decrease of 51% to $2M (expense), Stock-based Compensation in SGA decrease of 36% to $1.4M (expense), Rental Expense decrease of 33% to $1.2M (expense).

Equity composition

Common Stock $.001 Par, 03/11, 100M auth., 30,631,946 issd. Insiders own 61.68%. 07/08, Name changed from Zynex Medical Holdings, Inc.

9655 Maroon Circle
ENGLEWOOD
COLORADO 80112
US